Welcome to Edinburgh Biosciences
Our mission is to change how we treat cataracts by offering an alternative solution to cataract surgery. We have developed the world’s first non-invasive solution to treat and reverse cataracts.
Revisyon is a one-stop diagnosis and treatment solution that can be delivered in a primary care setting and not a hospital. Putting an end to the long waiting lists, the need for surgery, and a lengthy recovery time. It is a quick and easy procedure that can be delivered by your local optometrist.
Currently undergoing patient trials we aim to bring this innovative treatment solution to the market in early 2026.
A new treatment solution
65 million people worldwide suffer from cataracts, which is about 60% of the population over the age of 65. The fact is as the population ages, people are living for longer and the demand for cataract operations are likely to outstrip the supply of surgeons required.
For years, surgery has been the only solution to cataracts. It currently costs the NHS £300m per year for cataract surgery in the UK, and will become a greater burden and cost on the NHS which is already under enormous and growing pressure.
Revisyon uses light energy with specific wavelengths to reform the proteins in your eye which allows light to pass through allowing you to see clearly and brightly once again, thereby treating and reversing your cataracts.
Edinburgh Biosciences
Our mission is to change how we treat cataracts by offering an alternative solution to cataract surgery. We have developed the world’s first non-invasive solution to treat and reverse cataracts.
Revisyon is a one-stop diagnosis and treatment solution that can be delivered in a primary care setting and not a hospital. Putting an end to the long waiting lists, the need for surgery, and a lengthy recovery time. It is a quick and easy procedure that can be delivered by your local optometrist.
